Headline News about Entrada Therapeutics, Inc. - Common Stock

FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
February 24, 2025
Via Benzinga
Exposures
Product Safety

Beyond The Numbers: 4 Analysts Discuss Entrada Therapeutics Stock
November 06, 2024
Via Benzinga



Via Benzinga

Recap: Entrada Therapeutics Q4 Earnings
March 13, 2024
Via Benzinga




12 Health Care Stocks Moving In Thursday's Intraday Session
November 23, 2023
Via Benzinga


12 Health Care Stocks Moving In Wednesday's Intraday Session
November 22, 2023
Via Benzinga

Via Benzinga

Via Benzinga

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session
February 16, 2023
Via Benzinga


12 Health Care Stocks Moving In Wednesday's Intraday Session
February 15, 2023
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via Benzinga






12 Health Care Stocks Moving In Thursday's Intraday Session
December 08, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.